HOME >> BIOLOGY >> NEWS
Virus linked to Thoroughbred abortion epidemic

CORVALLIS, Ore. A new study by veterinary researchers at Oregon State University has linked a major epidemic of abortion a few years ago in Kentucky Thoroughbred mares to infection with vesivirus, the first time the virus has been suggested to cause this type of problem in horses.

The findings, which were just published in the American Journal of Veterinary Research, add another concern to the health issues associated with this virus, which is a part of the Caliciviridae viral family that can infect and cause health problems in many animal species, including humans.

About five years ago, mares in Kentucky's billion dollar Thoroughbred industry were losing foals at an alarming rate, with abortions of unknown cause happening up to 10 times more than usual on some farms. The problem eventually dissipated, and researchers since then have worked to identify the cause.

Many agents known to cause abortion in horses were considered at the time and ultimately dismissed, but some studies suggested at least part of the problem might be exposure to toxins in Eastern tent caterpillars found on some farms.

One new study examined 112 horses, both normal and those that had suffered abortions. It found that 40 percent of the mares with no reported abortion problems tested positive for vesivirus antibodies, but 64 percent of those from areas with high rates of abortion, or that had aborted their foals, had vesivirus exposure. All male horses and younger females not of breeding age tested negative for vesivirus antibodies.

According to researchers, these data suggest that vesivirus must now be considered a pathogenic virus associated with abortion in mares. It indicates that broodmares are being commonly exposed to vesivirus from unknown sources, they said, and that vesiviruses should be added to the panel of diagnostic tests for horses that abort.

It is not known whether exposure to horses, especially broodmares that abort, is a
'"/>

Contact: Dr. Alvin Smith
calicit@qwest.net
541-745-0707
Oregon State University
22-Jun-2006


Page: 1 2 3

Related biology news :

1. Virus widely used in gene therapy research yields important clues to genomic instability
2. The sweet science: Viruses switch grip to gain upper hand
3. Virus may control Australias "river rabbit"
4. Viruses can jump between primates and humans, researchers warn
5. Virus has catastrophic affect on red squirrels, research shows
6. Smooth sailing: Cruise Ship Virus tackled by UH, Baylor College of Medicine
7. New strategy developed to combat West Nile Virus
8. Virus chip detects new virus in prostate tumors
9. Secrets to antibodys success against West Nile Virus surprise scientists
10. Virus uses tiny RNA to evade the immune system
11. Virus-host interactions at sea effect global photosynthesis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Virus linked Thoroughbred abortion epidemic

(Date:7/23/2014)... The drought that has the entire country in its grip ... may also be responsible for the proliferation of a heat-loving ... rivers and hot springs, which the drought has made warmer ... died of an infection caused by this parasite after swimming ... the nose of an individual and travels to the brain. ...
(Date:7/23/2014)... available in German . ... cells, drive metabolic processes and transmit signals. To perform ... Scientists at the Max Planck Institute for Developmental Biology ... constructed of similar amino acid chains even when their ... that exist today arose from common precursors. Presumably, in ...
(Date:7/23/2014)... 2014 BioCatch, the global leader ... it has been named in Gartner,s Market Guide for ... Gartner,s well-known Magic Quadrant for Web Fraud Detection. ... of several vendors to deliver passive biometric analysis and ... standard feature of at least 30% of one-stop fraud ...
Breaking Biology News(10 mins):Diseases of another kind 2Protein evolution follows a modular principle 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 3
(Date:7/23/2014)... July 23, 2014 ... of Trendlines Agtech , announced it has ... Israel,s leading agricultural thermoplastics applications companies. ... Valentis,s technology combines nanocrystalline cellulose (NCC), a biodegradable, ... additional nanoparticles to produce highly improved polymeric films. ...
(Date:7/23/2014)... BRUSSELS , July 23, 2014 regulated ... its research and development pipeline with positive topline ... brivaracetam . This study was designed to evaluate ... (100 and 200 mg/day, without titration) compared to ... patients with partial-onset seizures, not fully controlled despite ...
(Date:7/23/2014)... Calif. , July 23, 2014  Sofinnova Ventures, ... firm, today announced the closing of Sofinnova Venture Partners ... and in excess of the initial fund target of ... entrepreneurs build successful biotechnology companies. Consistent with recent funds, ... promising later stage clinical programs, along with select investments ...
(Date:7/23/2014)... 23, 2014 OncLive® is pleased ... has joined its Strategic Alliance Partnership program. ... program, UNC Lineberger will have the opportunity to ... of its cutting-edge research initiatives, community-directed cancer prevention ... will work with OncLive to educate their peers ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
Cached News: